Pred-G®
Gentamicin 0.3% / Prednisolone acetate 1% · ophthalmic suspension
Antibiotic/Steroid
Approved uses
Steroid-responsive ocular inflammation with superficial bacterial infection or a risk of it, including chronic anterior uveitis and corneal injury from chemical, radiation or thermal burns or foreign body penetration
one drop into the conjunctival sac two to four times daily; during the initial 24 to 48 hours the dosing frequency may be increased, if necessary, up to 1 drop every hour; not more than 20 milliliters initially
Contraindications
- Most viral diseases of the cornea and conjunctiva, including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, and varicella
- Mycobacterial infection of the eye
- Fungal diseases of the ocular structures
- Known or suspected hypersensitivity to any ingredient of the preparation or to other corticosteroids
Gentamicin 0.3% and prednisolone acetate 1% suspension, 5 mL in 10 mL bottle
The corticosteroid suppresses the inflammatory response to a variety of agents and probably delays or slows healing. Gentamicin, an aminoglycoside, binds the bacterial ribosome to block protein synthesis. Gentamicin sulfate is active in vitro against susceptible strains of Staphylococcus aureus, Streptococcus pyogenes, Streptococcus pneumoniae, Enterobacter aerogenes, Escherichia coli, Haemophilus influenzae, Klebsiella pneumoniae, Neisseria gonorrhoeae, Pseudomonas aeruginosa, and Serratia marcescens. A review of annexin 1 reports that glucocorticoids may induce annexin 1 in inflammatory cells and that it may target cytosolic phospholipase A2 by direct enzyme inhibition.
Warnings & Precautions
- Elevated IOP: Prolonged corticosteroid use may result in glaucoma with optic nerve damage and defects in visual acuity and fields of vision; monitor IOP routinely when used 10 days or longer, use with caution in the presence of glaucoma, and check intraocular pressure frequently.
- Posterior subcapsular cataract: Prolonged corticosteroid use may produce cataract formation.
- Secondary ocular infection: Prolonged use may suppress the host response and increase the hazard of secondary ocular infections, and acute purulent infections of the eye may be masked or enhanced. Secondary ocular infection has occurred after use of combinations containing steroids and antimicrobials, and secondary bacterial ocular infection following suppression of host responses also occurs.
- Ocular irritation and punctate keratitis: Ocular irritation and punctate keratitis have been associated with the use of this suspension.
- Corneal and scleral thinning: Various ocular diseases and long-term topical corticosteroid use cause thinning, and use over thin tissue may lead to perforation.
- Fungal invasion: Suspect fungal infection in any persistent corneal ulceration where a corticosteroid has been used or is in use, and take fungal cultures when appropriate.
- Viral eye infections: Ocular steroids may prolong the course and may exacerbate the severity of many viral infections of the eye, including herpes simplex. Treatment of patients with a history of herpes simplex requires great caution, and frequent slit lamp microscopy is recommended.
- Delayed healing after cataract surgery: Steroid use may delay healing and increase the incidence of bleb formation.
- Not for injection: Never inject subconjunctivally or introduce directly into the anterior chamber of the eye.
- Initial prescription and renewal: The initial prescription and renewal beyond 20 mL should be made only after examination of the patient's intraocular pressure, slit lamp biomicroscopy and, where appropriate, fluorescein staining.
- Corneal epithelial toxicity: In rabbits, gentamicin sulfate was among the most toxic of eight topical antibiotic solutions tested on corneal epithelial wound healing, and fortified preparations did not seem more toxic than the 0.3% solutions.
Common Side Effects
- Ocular: Eye burning, stinging, irritation, ocular hyperemia, eye pain, eye discharge, increased lacrimation, eye edema, blurred vision, visual impairment, foreign body sensation.
- Superficial punctate keratitis: Reported occasionally, with onset typically after several days of use.
- Steroid component: In decreasing order of frequency, elevated IOP with possible development of glaucoma and infrequent optic nerve damage, then posterior subcapsular cataract formation, then delayed wound healing.
- Anti-infective component: Allergic sensitization is the reaction occurring most often from the antibiotic.
- Hypersensitivity: Ocular allergy such as conjunctivitis, angioedema such as tongue edema, and allergic skin reactions such as rash and contact allergy.
- Systemic: Dysgeusia.
Pregnancy: Systemic gentamicin in pregnant rats at roughly 500 times the maximum recommended ophthalmic human dose depressed newborn body weight, kidney weight and median glomerular counts, and prednisolone is teratogenic in mice at 1 to 10 times the human ocular dose. When dexamethasone, hydrocortisone and prednisolone were applied to both eyes of pregnant mice five times per day on days 10 through 13 of gestation, a significant increase in cleft palate was observed. No adequate well-controlled studies in pregnant women, so use only if the potential benefit justifies the potential risk to the fetus.
Lactation: Unknown whether topical administration produces detectable quantities in human milk; systemically administered corticosteroids do appear in human milk and could suppress growth, interfere with endogenous corticosteroid production, or cause untoward effects, so weigh discontinuing nursing against discontinuing the drug.
Safety and effectiveness in pediatric patients have not been established.